𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver® PTX® Drug-Eluting peripheral stent

✍ Scribed by Dvir, Danny; Torguson, Rebecca; Waksman, Ron


Book ID
119215105
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
252 KB
Volume
13
Category
Article
ISSN
1553-8389

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Overview of the 2006 Food and Drug Admin
✍ Tina L. Pinto Slottow; Ron Waksman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract Drug‐eluting stents (DES) seemed likely to mitigate the problem of restenosis and have become the predominant stent deployed during percutaneous coronary intervention (PCI). Sustained concerns about the rate of stent thrombosis (ST), particularly very late ST (>1 year following PCI) led